IMGN901
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IMGN901, covering 2014-11-21 to 2018-01-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]